4//SEC Filing
INFINITY PHARMACEUTICALS, INC. 4
Accession 0001209191-15-053771
CIK 0001113148operating
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:15 PM ET
Size
6.0 KB
Accession
0001209191-15-053771
Insider Transaction Report
Form 4
Palombella Vito J.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2015-06-15$10.97/sh−4,737$51,965→ 868 total
Holdings
- 6,741.146(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.83 to $11.10, inclusive. The reporting person undertakes to provide to Infinity Pharmaceuticals, Inc., any security holder of Infinity Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1.
Documents
Issuer
INFINITY PHARMACEUTICALS, INC.
CIK 0001113148
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001113148
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:15 PM ET
- Size
- 6.0 KB